Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating activities:
Net Loss	$ (70,335)	$ (38,042)
Adjustments to reconcile net loss to cash used in operating activities:
Provision for bad debt expense	1,712	554
Depreciation and amortization	17,950	18,764
Operating lease expenses	5,294	6,429
Loss on foreign currency, net	5,060	6,293
Deferred tax expense	(7,460)	(841)
Gain on debt and equity securities, net	(5,143)	(1,100)
Loss (gain) on equity method investments, net	932	(1,483)
Contingent consideration liability	(3,814)	1,987
Stock-based compensation	57,656	3,097
Gain on disposal of right-of-use assets	(1,883)	(62)
Other non-cash items	(1,471)	715
Changes in operating assets and liabilities
Changes in receivables, net of allowance	(28,269)	(30,643)
Changes in other assets	(18,486)	(10,879)
Changes in accounts payable	17,957	16,540
Changes in accrued expenses	28,996	7,921
Changes in contract liabilities	28,304	2,152
Changes in other liabilities	207	(14,125)
Changes in operating lease liabilities	(4,949)	(5,584)
Payment of severance benefits, net of cash transferred	136	(2,356)
Net cash provided by (used in) operating activities	22,394	(40,663)
Investing activities:
Proceeds from maturities of short-term investments	63,299	7,725
Proceeds from sale of debt and equity securities	2,977
Purchases of property and equipment	(679)	(9,326)
Proceeds from sale of equity method investments	5,927
Payment made for short-term investments	(68,035)	(7,725)
Payment made for loan receivable	(237)	(12,307)
Purchases of intangible assets	(4,669)	(5,169)
Purchases of equity method investments	(5,798)	(687)
Disposal of businesses, net of cash disposed	(360)	2,031
Other investing activities	269	(17)
Net cash used in investing activities	(7,306)	(25,475)
Financing activities:
Proceeds from issuance of common stock upon initial public offering, net of underwriting discounts and commissions	292,950
Proceeds from issuance of common stock related to private placement	50,000
Payments of initial public offering costs	(1,898)
Repayments of short-term borrowings	(3,647)	(6,761)
Payment of contingent consideration related to business acquisition	(1,352)	(1,983)
Net cash provided by (used in) financing activities	336,053	(8,744)
Effect of exchange rate changes on cash and cash equivalents	(10,581)	(5,333)
Cash and cash equivalents:
Net increase (decrease) in cash and cash equivalents	340,560	(80,215)
Cash and cash equivalents at beginning of the year	231,745	279,709
Cash and cash equivalents at end of the year	572,305	199,494
Supplemental disclosure:
Income taxes paid	15,477	18,440
Interest paid	85	$ 88
Reclassification of deferred offering costs to additional paid-in capital upon IPO	11,215
Deferred offering costs not yet paid	9,316
Reclassification of debt and equity securities to equity method investments	$ 18,256